San Francisco, CA, United States of America

Frank Kayser

This inventor holds 48 USPTO granted patents and 15 published patent applications, plus 9 CIPO patents and 13 EPO patents, primarily in Antiviral Compositions. Top assignees: Amgen Inc., Merck + Co., Inc., Japan Tobacco Inc.. Active years: 1997-2025.

USPTO Granted Patents = 48 (Patent Applications = 15)

% Patents Active = 75.0

CIPO Patents = 9 (Patent Applications = 8)

EPO Patents = 13 (Patent Applications = 15)

Average Co-Inventor Count = 7.2

ph-index = 11

Forward Citations = 359(Granted Patents)

Location History:

Hoboken, NJ (US) (1997 - 2003)
San Francisco, CA (US) (2001 - 2024)

Company Filing History:

Reiley Pharmaceuticals, Inc.

patents

where one patent can have more than one assignee

Years Active: 1997-2025

Loading Chart...

Areas of Expertise:

Antiviral Compositions

MDM2 Inhibitors

Triazole Agonists

Ion Channel Inhibitors

Piperidinone Derivatives

Furanopyrimidines

Heterocyclic Compounds

Chemokine Receptor Modulators

Immunosuppressant Compounds

Atherosclerosis Treatments

FXR Modulators

Aromatic Derivatives

48 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12459935 - Broad spectrum antiviral compositions and methods (2025-11-04),

2. 11976058 - Aromatic derivatives, preparation methods, and medical uses thereof (2024-05-07),

3. 11459321 - Broad spectrum antiviral compositions and methods (2022-10-04),

4. 11407721 - CIS-morpholinone and other compounds as MDM2 inhibitors for the treatment of cancer (2022-08-09),

5. 11279697 - Aromatic derivative, preparation method for same, and medical applications thereof (2022-03-22),

6. 11046680 - Heteroaryl-substituted triazoles as APJ receptor agonists (2021-06-29),

7. 10736883 - Triazole furan compounds as agonists of the APJ receptor (2020-08-11),

8. 10562857 - Ion channel inhibitory compounds, pharmaceutical formulations, and uses (2020-02-18),

9. 10221162 - Triazole agonists of the APJ receptor (2019-03-05),

10. 9868721 - Triazole agonists of the APJ receptor (2018-01-16),

11. 9850183 - Conjugates derived from non-steroidal anti-inflammatory drugs and methods of use thereof in imaging (2017-12-26),

12. 9745286 - Triazole agonists of the APJ receptor (2017-08-29),

13. 9656997 - Triazole agonists of the APJ receptor (2017-05-23),

14. 9593129 - Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer (2017-03-14),

15. 9573936 - Triazole agonists of the APJ receptor (2017-02-21),

Title: The Inventor Profile of Frank Kayser

Introduction: Frank Kayser is a renowned inventor based in San Francisco, CA, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: Frank Kayser holds several patents in the areas of technology, healthcare, and sustainability, showcasing his diverse range of interests and expertise.

Career Highlights: With a career spanning over two decades, Frank Kayser has established himself as a prolific inventor with a keen eye for identifying gaps in the market and developing unique solutions to address them.

Collaborations: Throughout his career, Frank Kayser has collaborated with leading companies, research institutions, and universities to bring his inventions to life, demonstrating his ability to work effectively in multidisciplinary teams.

Conclusion: Frank Kayser's passion for innovation and his relentless drive to push the boundaries of what is possible make him a standout figure in the world of inventors, with a legacy that continues to inspire future generations of innovators.